Carvedilol ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats

European Journal of Pharmacology

Volumn 567, Issue 3, 2007, Pages 223-230

  Fu, Guo Sheng ^a   Huang, He ^a   Chen, Fei ^a   Wang, Hui Ping ^b   Qian, Ling Bo ^b   Ke, Xi Ye ^a   Xia, Qiang ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Carvedilol; Diabetes; Endothelium function; NOS3

Indexed keywords

ACETYLCHOLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE; NITROPRUSSIDE SODIUM; SERINE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD LEVEL; BLOOD VESSEL REACTIVITY; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION; HEART FAILURE; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; STREPTOZOCIN DIABETES; TREATMENT OUTCOME; UPREGULATION; VASCULAR ENDOTHELIUM; VASODILATATION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AORTA, THORACIC; BLOOD GLUCOSE; BLOOD PRESSURE; BLOTTING, WESTERN; BODY WEIGHT; CARBAZOLES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ISOMETRIC CONTRACTION; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROPANOLAMINES; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34250862656     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.02.036     Document Type: Article

References (37)

1. Bojunga J., Dresar-Mayert B., Usadel K.H., Kusterer K., and Zeuzem S. Antioxidative treatment reverses imbalances of nitric oxide synthase isoform expression and attenuates tissue-c GMP activation in diabetic rats. Biochem. Biophys. Res. Commun. 316 (2004) 771-780
2. Bojunga J., Nowak D., Mitrou P.S., Hoelzer D., Zeuzem S., and Chow K.U. Antioxidative treatment prevents activation of death-receptor- and mitochondrion-dependent apoptosis in the hearts of diabetic rats. Diabetologia 47 (2004) 2072-2080
3. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
4. Bucci M., Roviezzo F., Brancaleone V., Lin M.I., Di Lorenzo A., Cicala C., Pinto A., Sessa W.C., Farneti S., Fiorucci S., and Cirino G. Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 721-726
5. Calo L., Giacon B., Davis P.A., Pagnin E., Piccin A., Riegler P., Huber W., Antonello A., and Semplicini A. Oxidative stress and TGFbeta in kidney-transplanted patients with cyclosporin-induced hypertension. Effect of carvedilol and nifedipine. Clin. Nephrol. 58 (2002) 103-110
6. Cohen R.A. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog. Cardiovasc. Dis. 38 (1995) 105-128
7. Cosentino F., Hishikawa K., Katusic Z.S., and Luscher T.F. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96 (1997) 25-28
8. Dandona P., Karne R., Ghanim H., Hamouda W., Aljada A., and Magsino Jr. C.H. Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids. Circulation 101 (2000) 122-124
9. El-Omar M.M., Lord R., Draper N.J., and Shah A.M. Role of nitric oxide in posthypoxic contractile dysfunction of diabetic cardiomyopathy. Eur. J. Heart Fail. 5 (2003) 229-239
10. Fahim M., Hussain T., and Mustafa S.J. Relaxation of rat aorta by adenosine in diabetes with and without hypertension: role of endothelium. Eur. J. Pharmacol. 412 (2001) 51-59
11. Furchgott R.F. Endothelium-derived relaxing factor: discovery, early studies, and identification as nitric oxide. Biosci. Rep. 19 (1999) 235-251
12. Harris K.H., and MacLeod K.M. Influence of the endothelium on contractile responses of arteries from diabetic rats. Eur. J. Pharmacol. 153 (1988) 55-64
13. Hiremath A.N., Hu Z.W., and Hoffman B.B. Desensitization of alpha-adrenergic receptor-mediated smooth muscle contraction: role of the endothelium. J. Cardiovasc. Pharmacol. 18 (1991) 151-157
14. Huszka M., Kaplar M., Tornai I., Palatka K., Laszlo P., and Udvardy M. The association of reduced endothelium derived relaxing factor-NO production with endothelial damage and increased in vivo platelet activation in patients with diabetes mellitus. Thromb. Res. 86 (1997) 173-180
15. Ibrahim M.A., Kanzaki T., Yamagata S., Satoh N., and Ueda S. Effect of diabetes on aortic nitric oxide synthesis in spontaneously hypertensive rats; does captopril modulate this effect?. Life Sci. 77 (2005) 1003-1014
16. Kalinowski L., Dobrucki L.W., Szczepanska-Konkel M., Jankowski M., Martyniec L., Angielski S., and Malinski T. Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action. Circulation 107 (2003) 2747-2752
17. Kubo T., Azevedo E.R., Newton G.E., Parker J.D., and Floras J.S. Lack of evidence for peripheral alpha(1)-adrenoceptor blockade during long-term treatment of heart failure with carvedilol. J. Am. Coll. Cardiol. 38 (2001) 1463-1469
18. Li H., and Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J. Pathol. 190 (2000) 244-254
19. Lopez B.L., Christopher T.A., Yue T.L., Ruffolo R., Feuerstein G.Z., and Ma X.L. Carvedilol, a new beta-adrenoreceptor blocker antihypertensive drug, protects against free-radical-induced endothelial dysfunction. Pharmacology 51 (1995) 165-173
20. Lu Y.L., Hu S.J., Shen Z.J., and Shao Y.C. Changes of macrovascular endothelial ultrastructure and gene expression of endothelial nitric oxide synthase in diabetic rats. Chin. Med. J. (Engl.) 117 (2004) 1165-1169
21. Maritim A.C., Sanders R.A., and Watkins III J.B. Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Biol. 17 (2003) 24-38
22. Noguchi N., Nishino K., and Niki E. Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation. Biochem. Pharmacol. 59 (2000) 1069-1076
23. Oyadomari S., Gotoh T., Aoyagi K., Araki E., Shichiri M., and Mori M. Coinduction of endothelial nitric oxide synthase and arginine recycling enzymes in aorta of diabetic rats. Nitric Oxide 5 (2001) 252-260
24. Paskaloglu K., Sener G., and Ayangolu-Dulger G. Melatonin treatment protects against diabetes-induced functional and biochemical changes in rat aorta and corpus cavernosum. Eur. J. Pharmacol. 499 (2004) 345-354
25. Qian L.B., Wang H.P., Qiu W.L., Huang H., Bruce I.C., and Xia Q. Interleukin-2 protects against endothelial dysfunction induced by high glucose levels in rats. Vascul. Pharmacol. 45 (2006) 374-382
26. Qvigstad E., Osnes J.B., Sandnes D., Schiander I., Bokenes J., Sjaastad I., and Skomedal T. Carvedilol blockade of rat myocardial alpha1-adrenoceptors. Eur. J. Pharmacol. 481 (2003) 83-89
27. Rodriguez-Manas L., Angulo J., Vallejo S., Peiro C., Sanchez-Ferrer A., Cercas E., Lopez-Doriga P., and Sanchez-Ferrer C.F. Early and intermediate Amadori glycosylation adducts, oxidative stress, and endothelial dysfunction in the streptozotocin-induced diabetic rats vasculature. Diabetologia 46 (2003) 556-566
28. Schulingkamp R.J., Aloyo V., Tallarida R.J., and Raffa R.B. Changes in aorta alpha1-adrenoceptor number and affinity during one year of streptozotocin-induced diabetes in rats. Pharmacology 74 (2005) 23-30
29. Soga M., Kamal F.A., Watanabe K., Ma M., Palaniyandi S., Prakash P., Veeraveedu P., Mito S., Kunisaki M., Tachikawa H., Kodama M., and Aizawa Y. Effects of angiotensin II receptor blocker (candesartan) in daunorubicin-induced cardiomyopathic rats. Int. J. Cardiol. 110 (2006) 378-385
30. Srinivasan S., Hatley M.E., Bolick D.T., Palmer L.A., Edelstein D., Brownlee M., and Hedrick C.C. Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells. Diabetologia 47 (2004) 1717-1734
31. Tesfamariam B., Brown M.L., and Cohen R.A. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J. Clin. Invest. 87 (1991) 1643-1648
32. Turko I.V., Marcondes S., and Murad F. Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase. Am. J. Physiol, Heart Circ. Physiol. 281 (2001) H2289-H2294
33. Wang S.X., Xiong X.M., Song T., and Liu L.Y. Protective effects of cariporide on endothelial dysfunction induced by high glucose. Acta Pharmacol. Sin. 26 (2005) 329-333
34. Weber L.P., and MacLeod K.M. Contractile responses of caudal arteries from diabetic rats to adrenergic nerve stimulation. J. Vasc. Res. 31 (1994) 25-32
35. Xavier F.E., Davel A.P., Rossoni L.V., and Vassallo D.V. Time-dependent hyperreactivity to phenylephrine in aorta from untreated diabetic rats: role of prostanoids and calcium mobilization. Vascul. Pharmacol. 40 (2003) 67-76
36. Xydas S., Kherani A.R., Chang J.S., Klotz S., Hay I., Mutrie C.J., Moss G.W., Gu A., Schulman A.R., Gao D., Hu D., Wu E.X., Wei C., Oz M.C., and Wang J. Beta(2)-Adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy. J. Pharmacol. Exp. Ther. 317 (2006) 553-561
37. Yue T.L., Mckenna P.J., Gu J.L., Cheng H.Y., Ruffolo Jr. R.R., and Feuerstein G.Z. Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells. Hypertension 22 (1993) 922-928